Literature DB >> 35523871

Are COVID surges becoming more predictable? New Omicron variants offer a hint.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Virology

Mesh：

Year:  2022        PMID： 35523871     DOI： 10.1038/d41586-022-01240-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Recent advances in small-molecular therapeutics for COVID-19.

Authors:  Lei Zhong; Zhipeng Zhao; Xuerun Peng; Jun Zou; Shengyong Yang
Journal:  Precis Clin Med       Date:  2022-09-24

2.  The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic - Correspondence.

Authors:  Ranjan K Mohapatra; Venkataramana Kandi; Ashish K Sarangi; Sarika Verma; Hardeep Singh Tuli; Sandip Chakraborty; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-06-08       Impact factor: 13.400

3.  Moving targets: COVID-19 vaccine efficacy against Omicron subvariants.

Authors:  Maria Karolaynne da Silva; Umberto Laino Fulco; Edilson Dantas da Silva Júnior; Jonas Ivan Nobre Oliveira
Journal:  Mol Ther       Date:  2022-07-31       Impact factor: 12.910

Review 4.  Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.

Authors:  Ailan Xu; Bixia Hong; Fuxing Lou; Shuqi Wang; Wenye Li; Amna Shafqat; Xiaoping An; Yunwei Zhao; Lihua Song; Yigang Tong; Huahao Fan
Journal:  MedComm (2020)       Date:  2022-08-16

5.  SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period.

Authors:  Su Lan Yang; Hoon Shien Teh; Jing Lian Suah; Masliyana Husin; Wen Yea Hwong
Journal:  Lancet Reg Health West Pac       Date:  2022-08-27

6.  COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.

Authors:  Sherrie L Kelly; Epke A Le Rutte; Maximilian Richter; Melissa A Penny; Andrew J Shattock
Journal:  Infect Dis Ther       Date:  2022-09-12

7.  Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.

Authors:  Rommel Guevara; Belén Prado-Vivar; Sully Márquez; Erika B Muñoz; Mateo Carvajal; Juan José Guadalupe; Mónica Becerra-Wong; Stefanie Proaño; Rosa Bayas-Rea; Josefina Coloma; Michelle Grunauer; Gabriel Trueba; Patricio Rojas-Silva; Verónica Barragán; Paúl Cárdenas
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073

8.  Evolving trend change during the COVID-19 pandemic.

Authors:  Liping Gao; Canjun Zheng; Qi Shi; Kang Xiao; Lili Wang; Zhiguo Liu; Zhenjun Li; Xiaoping Dong
Journal:  Front Public Health       Date:  2022-09-20

9.  Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Authors:  Ji-Min Seo; Bobin Kang; Rina Song; Hanmi Noh; Cheolmin Kim; Jong-In Kim; Minsoo Kim; Dong-Kyun Ryu; Min-Ho Lee; Jeong-Sun Yang; Kyung-Chang Kim; Joo-Yeon Lee; Hansaem Lee; Hye-Min Woo; Jun-Won Kim; Jung-Ah Choi; Manki Song; Monika Tomaszewska-Kiecana; Anna Wołowik; Agnieszka Kulesza; Sunghyun Kim; Keumyoung Ahn; Nahyun Jung; Soo-Young Lee
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

10.  Characteristics of hospitalised COVID-19 patients during the first two pandemic waves, Gauteng.

Authors:  Mpho L Sikhosana; Waasila Jassat; Zinhle Makatini
Journal:  S Afr J Infect Dis       Date:  2022-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.